《大行報告》摩通微升信義光能(00968.HK)目標價至24元 評級「增持」
摩根大通發表研究報告指,信義光能(00968.HK)2020財年盈利按年增長89%,期內已受到太陽能發電場業務一次性影響所拖累,但業績表現仍達到早前盈喜的近上限。
報告指,信義光能太陽能玻璃業務表現向好,毛利率較預測高出3個百分點,相信是由於成本控制及產品組合所致,將2020至2021財年盈利預測上調2%及5%。
該行指,與穩健的基本面相反,信義光能的股價自農曆新年以來下跌了18%,對比同期國指跌幅為5%,認為現時是買入的機會,重申「增持」評級,目標價由23.9元升至24元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.